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Abstract
Purpose Body adiposity index (BAI) is a novel index for
the assessment of percentage fat mass (FM%). We tested
the association between BAI and metabolic outcomes in
overweight and obese women of different ages.
Methods 260 young women (24.7 ± 5.3 years, 31.0 ±
5.0 kg/m2) and 328 older women (66.9 ± 4.6 years,
34.8 ± 4.7 kg/m2) were recruited. BAI was calculated
using hip circumference and height. Bioimpedance analysis
was used to measure FM%. Metabolic risk was assessed
using a composite z score integrating standardised mea-
surements of fasting glucose, total cholesterol, liver
enzymes and triglycerides.
Results The association between BAI and FM% was
modest in both young (r = 0.56, p \ 0.001) and older
(r = 0.49, p \ 0.001) groups. BAI was directly associated
with metabolic risk in young women (r = 0.29,
p \ 0.001), whereas it showed a weak, inverse association
in the older group (r = -0.14, p = 0.01).
Conclusions BAI validity needs to be re-assessed in older
individuals for better definition of its predictive accuracy.
Keywords Obesity  Body composition  Fat mass 
Metabolic risk  Ageing
Introduction
Body mass index (BMI) represents the most widely and
epidemiologically used marker of excess adiposity. None-
theless, BMI is known to be of limited accuracy, being also
different for males and females with similar percent body
adiposity [1].
Although direct assessments of body composition would
be ideal for accurate measures of adiposity, such tools are
not readily available in clinical and epidemiological set-
tings. As such, identifying the predictive value of surrogate
measures of adiposity in relation to health outcomes is
needed.
Recently, the body adiposity index (BAI) has been
proposed as an alternative parameter for the estimation of
fat mass percentage (FM%). The BAI originally proposed
by Bergman et al. [1] (BAIBergman) is calculated as the ratio
between hip circumference and height, and has been used
to measure adiposity and as a predictor of cardio-metabolic
risk [1–4]. The BAIBergman was initially validated in His-
panic and African-American populations against FM%
measured by dual energy X-ray absorptiometry (DXA) [1,
2]. In addition to being an easy, non-invasive and low-cost
technique, the BAIBergman has advantages over BMI since it
does not require measurements of body weight (more
portable), and importantly, the relationship between hip
circumference and height is independent and has a stronger
correlation with FM% [2].
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Although several studies have investigated the associa-
tion between BAI and health outcomes, some inconsistent
results on the advantages of BAI over standard anthropo-
metric measurements highlight the need for further
research [5]. A number of studies have not been able to
support the validity of BAI in selected cohorts of individ-
uals, and have also reported a weaker association with
metabolic risk factors as compared to BMI and waist cir-
cumference (WC) [4, 6–11].
Subsequently, an attempt was made to modify the
BAIBergman algorithm [1, 2], after validation in a Caucasian
population, using data from the Fels longitudinal study
(BAIFels) [7]. Nonetheless, the association of both BAI
algorithms with metabolic risk remained inferior as com-
pared to BMI and WC [7].
Noticeably, most of the studies investigating the asso-
ciation between BAI and health outcomes were conducted
in young and middle-aged subjects or in elderly subjects
with chronic disease (kidney failure) [12] raising questions
regarding the generalizability of the BAI index validity in
older aged populations.
The aim of this study was to evaluate the association
between the BAI (BAIBergman [1, 2], BAIFels [7]) with
established markers of metabolic risk including fasting
glucose, total cholesterol, liver enzymes, triglycerides, in
young (age 18–42 years) and older (age 60–83 years)
overweight and obese women from a clinical population in
southern Italy. Our secondary aim was to investigate the
association of both BAI indexes with anthropometric adi-
posity indexes (BMI, WC) and body composition measures
(FM%). Our hypothesis was that BAI would predict met-
abolic risk in both young and older individuals, showing a
strong association with FM%.
Methods
The study was conducted at the weight loss clinic of the
Department of Neuroscience, Section of Physiology and
Nutrition of the University of Naples ‘‘Federico II’’,
Southern Italy. The Research and Ethics Committee of the
Department of Neuroscience of the University of Naples
‘‘Federico II’’ approved the project. All subjects provided
written informed consent.
Subjects
Young cohort
Two hundred and sixty consecutive young overweight and
obese adult women (age range 18–42 years) attending a weight
loss clinic between January 2008 and December 2011 were
included in a study exploring the sources of variability in body
composition and metabolism [13]. Exclusion criteria included:
pregnancy and breastfeeding, cancer or medication use that
may have influenced body weight regulation. Patients with
thyroid disorders on a stable thyroid replacement therapy,
dyslipidaemia and hypertension were included, as were those
with type 2 diabetes unless on insulin therapy.
Older cohort
Three hundred and twenty-eight consecutive overweight
and obese older women (age range 60–83 years) attending
an outpatient nutritional clinic for older subjects between
January 2008 and December 2011 were included in the
study. Similarly, subjects were excluded if they reported a
history of disease or taking prescribed medications inter-
fering with body weight. Patients with thyroid disorders on
a stable thyroid replacement therapy, dyslipidaemia and
hypertension were included, as were those with type 2
diabetes unless on insulin therapy.
Measurements
Anthropometry
Standing height, weight and waist circumference were
measured with subjects wearing light clothing. The BMI,
BAIBergman and BAIFels were computed according to spe-
cific algorithms, which take the following form:
BMI kg/m2
 
:
weight kgð Þ
height mð Þ2
BAIBergman FM%ð Þ 1; 2½ : hip circumference cmð Þð Þ
height mð Þ1:5
 18
BAIFels FM%ð Þ 7½ : 1:26  hip circumference cmð Þð Þ
height mð Þ1:4
 32:85
Bioimpedance analysis
Bioimpedance measurements (BIA-101, RJL/Akern Sys-
tems, Clinton Township, MI, USA) were conducted
according to standardised protocols to measure FFM and
FM, using the manufacturer’s equations. Briefly, the mea-
surement protocol required subjects to lie supine on a bed
with arm and legs open to create a 45 angle. Electrodes
were then attached to specific anatomical landmarks on the
wrist and ankle areas of the non-dominant side for the
measurement of the electrical resistance measured as the
drop in voltage between the electrodes injecting the small
alternate electrical current and the electrodes measuring the
intensity of the current. Body composition data were
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adjusted for height to calculate the fat mass index
(FMI = FM divided by height2) and fat-free mass index
(FFMI = FFM divided by height2) [14].
Clinical biochemistry
Each patient was invited to have 8-h fasting biochemical tests
at their local hospital or clinical biochemistry service and these
results were collected at the first appointment. The biochemi-
cal tests included in the analysis are: alanine and aspartate
amino-transferases, total cholesterol, triglycerides and fasting
plasma glucose. A continuous metabolic risk z score was
computed as the average of the z scores for the individual traits,
to evaluate differences in risk between the two age groups [15].
The risk z score was calculated using data on alanine amino-
transferase (ALT), aspartate amino-transferase (AST), total
cholesterol, triglycerides and fasting plasma glucose. For each
of these variables, a z score was computed as the number of SD
units from the sample mean after normalisation of the vari-
ables, i.e., z = ([value - mean]/SD).
Statistical analysis
Continuous variables were described using summary sta-
tistics. Student’s t test for independent samples was used to
detect differences between age groups (young versus old).
Analysis of covariance was also performed to test whether
differences in metabolic risk z score between the two
groups were explained by age, BMI, WC, BAI, FMI and
FFMI. A paired t test was used to evaluate differences
between the two BAI measures (BAIBergman and BAIFels).
Correlation analysis among anthropometric adiposity
indexes, FM%, metabolic outcomes and derived metabolic
risk z score was performed for each age group. Multiple
linear regression was used to test the association between
BAI and metabolic risk z score for each age group. Three
models were built in order to evaluate the association
between BAI and metabolic risk (BAI ? age; Model 1)
and after adjustment for anthropometric (Model
1 ? BMI ? WC; Model 2) and body composition vari-
ables (Model 2 ? FMI ? FFMI; Model 3).
SPSS 17 software (SPSS for Windows, SPSS Inc, USA)
was used for the statistical analysis. The significance cut-
off value was taken at 0.05.
Results
Descriptive statistics
Older women had a significantly higher average BMI
(D = ?3.7 kg/m2, p \ 0.001) and WC (D = 16.6 cm,
p \ 0.001) than young women. The two groups were not
different for body weight or hip circumference and the dif-
ference in BMI was essentially linked to the significantly
shorter stature of older women (D = -7.2 cm, p \ 0.001).
Fat mass was higher in older subjects before
(DFM = ?6.2 kg, p \ 0.001) and after adjustment for height
(DFMI = ?3.8 kg/m
2, p \ 0.001), whereas the difference in
FFM between the two groups disappeared after age-adjust-
ment (FFMI, p = 0.33).
Both BAI measures were significantly higher in older
subjects and BAIFels estimates were significantly greater
than BAIBergman in both young (D = ?2.8, p \ 0.001) and
older (D = ?3.7, p \ 0.001) women (Table 1). The ana-
lysis of the metabolic parameters showed significant dif-
ferences between young and older women for total
cholesterol, triglycerides, glucose, liver enzymes (ALT,
AST) and metabolic risk z score (Table 1).
Correlation analysis
Since the association among the two BAI measures and other
indexes of adiposity and metabolic factors was comparable,
Table 1 Body composition and metabolic characteristics of young
and old overweight and obese women
Young
(N = 260)
Old
(N = 328)
p
Mean SD Mean SD
Age (years) 24.7 5.3 66.9 4.6 \0.001
Weight (kg) 80.3 14.5 81.7 12.3 0.16
Height (cm) 160.6 6.0 153.3 6.4 \0.001
Body mass index (kg/m2) 31.0 5.0 34.8 4.7 \0.001
Waist circumference (cm) 89.1 12.1 105.7 11.2 \0.001
Hip circumference (cm) 111.9 10.5 112.2 9.6 0.66
Fat mass (kg) 30.7 10.1 36.9 8.3 \0.001
Fat-free mass (kg) 49.6 5.8 44.8 5.8 \0.001
Fat mass (%) 37.4 6.2 44.7 4.3 \0.001
Fat-free mass (%) 62.5 6.2 55.2 4.3 \0.001
Fat mass index (kg/m2) 11.8 3.6 15.7 3.3 \0.001
Fat-free mass index (kg/m2) 19.2 1.9 19.0 2.0 0.32
Body adiposity indexBergman 37.0 5.2 41.2 6.0 \0.001
Body adiposity indexFels 39.8 6.8 45.0 7.7 \0.001
Total cholesterol (mg/dL) 177.4 32.9 214.6 41.8 \0.001
Triglycerides (mg/dL) 89.9 51.3 133.1 55.8 \0.001
Glucose (mg/dL) 85.0 11.0 102.7 23.2 \0.001
AST (IU/L) 19.2 7.1 24.9 18.3 \0.001
ALT (IU/L) 21.1 15.5 25.8 15.0 \0.001
Metabolic risk z score -1.7 2.2 1.4 2.8 \0.001
Body adiposity index: unit not specified as calculated as ratio between
hip circumference and height (see ‘‘Methods’’). The calculation of the
metabolic risk z score is described in the ‘‘Methods’’ section
N number of subjects, AST aspartate amino transferase, ALT alanine
amino transferase
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only results for the BAIBergman were reported (Table 2). The
association between BAI and BMI was stronger than the
association between WC and FM% and correlations values
were consistently higher in younger women. The BAI
showed a pronounced age-interaction since a direct associ-
ation was found with most metabolic risk factors in young
women, whereas the direction of the association was
reversed in older women. BMI and WC were directly asso-
ciated with most of the metabolic risk factors in young
women whereas the only factors associated with BMI and
WC in older women were AST (r = 0.12, p = 0.02) and
glucose (r = 0.13, p = 0.02) (Table 2).
Multiple linear regression
The association of BAI with metabolic risk z score was
immediately removed in young women by adding BMI
(p = 0.006) to the model, whereas both BMI (p \ 0.001)
and BAI (p \ 0.001) were associated with metabolic risk in
older women (Model 1). The addition of WC removed the
effect of BMI in young women but not in older women
(Model 2). The role of central adiposity (WC) as a risk factor
for metabolic risk remained in young women (p = 0.03)
after entering body composition variables to the model (FMI,
FFMI) whereas the protective role of BAI for metabolic
risk was substantiated in older women (B ± SE =
-0.16 ± 0.03, p \ 0.001) (Model 3) (Table 3).
Discussion
The association between the BAI with commonly applied
clinical outcomes of metabolic health varied in a clinical
population of young and older women. In line with previ-
ous results [6–11], the BAI was not associated with any
metabolic outcomes in young women. In contrast, higher
BAI values seemed to be associated with a better metabolic
profile in older women. The protective effect of the BAI on
the cumulative metabolic risk in the older aged group was
not removed when the model was fully adjusted by adi-
posity (BMI, WC, FMI) and fat-free mass (FFMI).
Therefore, our findings raise the question whether the BAI
is a useful indicator of metabolic risk in the older aged
population.
We had initially conjectured that the validation of the
BAI in a Hispanic and African-American population
(BAIBergman) [1, 2] could amplify the misclassification bias
in our analyses, whereas the optimization of the BAI for-
mula from a Caucasian sample (BAIFels) [7] could have
resolved such methodological bias. However, the two BAI
measures produced essentially equivalent results in the
prediction of metabolic risk for both young and older
subjects. However, the BAIFels produced significantly
greater values than the BAIBergman in the assessment of
adiposity, and the agreement with FM% was dependent on
age. Furthermore, the BAIBergman was associated with
FM% in young women whereas in the older group a
stronger association with FM% was observed with the
updated index (BAIFels). The interpretation of these results
is difficult since our study has relied on measures of bio-
impedance analysis for the assessment of body composi-
tion, rather than DXA, which gives a more refined
assessment. Further studies using more accurate body
composition methods (DXA, 4-compartment models)
evaluating the agreement between BAI and FM% in ageing
populations are needed.
Table 2 Correlation between adiposity indexes and their association with metabolic outcomes in young and old overweight and obese women
BAIBergman BAIFels Body mass index (kg/m
2) Waist circumference (cm) Fat mass (%)
Young Old Young Old Young Old Young Old Young Old
Body mass index (kg/m2) 0.81** 0.69** 0.82** 0.70** – – – – – –
Waist circumference (cm) 0.57** 0.40** 0.59** 0.42** 0.85** 0.78** – – – –
Fat mass (%) 0.56** 0.49** 0.58** -0.50** 0.71** 0.67** 0.65** 0.58** – –
Total cholesterol (mg/dL) 0.04 -0.10* 0.04 -0.11* 0.07 -0.12* 0.10 -0.08 0.02 -0.05
Triglycerides (mg/dL) 0.23** -0.18** 0.24** -0.18* 0.30** -0.02 0.32** 0.06 0.16* -0.05
Glucose (mg/dL) 0.15* -0.05 0.15* -0.05 0.14* 0.07 0.13* 0.13* 0.13* -0.04
AST (IU/L) 0.14* 0.006 0.15* 0.005 0.12* 0.12* 0.10 0.05 0.09 0.03
ALT (IU/L) 0.24** -0.06 0.25** -0.05 0.27** 0.09 0.26** 0.05 0.19* 0.06
Metabolic risk z score 0.29** -0.14* 0.29** -0.14* 0.32** 0.06 0.33** 0.08 0.20** 0.01
Body adiposity index: calculated as ratio between hip circumference and height (see ‘‘Methods’’). The calculation of the metabolic risk z score is
described in the ‘‘Methods’’ section
AST aspartate amino transferase, ALT alanine amino transferase
* p \ 0.05; ** p \ 0.01
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The association of the BAI with FM% measured by
DXA has been investigated in several studies, with mixed
findings. Johnson et al. [7] found that the BAI was more
strongly associated with FM% than BMI but the agreement
was still poor at lower levels of FM%. Two clinical studies
tested the performance of the BAI in lipodystrophic sub-
jects [16] and older subjects (mean age 64 years) with
chronic kidney failure [12] and both found that BAI was
more closely associated with adiposity as compared to
BMI. However, other studies reported poor associations of
the BAI with FM% in severe obese women [17] and
inaccuracy in the index for measuring changes in FM%
over a period of 1 year in middle-aged women (SWAN
cohort) [18].
The results of the association between the BAI and
cardio-metabolic risk are unconvincing and favour the use
of BMI and WC. In particular, WC provides an indirect
assessment of centralised adipose tissue accumulation,
which is closely linked to visceral fat depots and to the
pathogenesis of metabolic disorders such as insulin resis-
tance and endothelial dysfunction [8]. In the FATE cohort,
BAI did not emerge as a predictor of vascular health in
multiple regression models including other anthropometric
and body composition measures [19]. The SAPHIR study
showed that BAI and BMI were both weakly associated
with glucose, lipids and blood pressure in 1,770 male and
female between 40 and 70 years of age [4]. The Bogalusa
study reported that BAI was a poorer predictor than BMI
and WC of blood pressure, lipid, insulin and glucose levels
in analyses stratified by age, gender, ethnicity and BMI
categories [9]. The predictive value of the BAI for type 2
diabetes was recently tested in two large longitudinal
studies: the European Prospective Investigation into Can-
cer and Nutrition (EPIC)-Potsdam study (9,729 men,
15,438 women) and the Cooperative Health Research in the
Region of Augsburg (KORA) study (5,573 men, 5,628
women). The results showed that WC in men and hip cir-
cumference in women were better predictors of FM% than
BAI and BMI. BAI was not as strong a predictor of dia-
betes as BMI, while waist circumference was the strongest
predictor in both cohorts [11].
An important limitation of the study is the cross-sec-
tional design, which restricts the interpretation of the
associations between body composition variables and
metabolic risk factors. The analyses are based on a clin-
ically representative population and results need to be
interpreted with caution as they may not generalise to
other populations. Also the blood biochemistry data were
obtained from different biochemistry analytical laborato-
ries. However, this would be expected to introduce ran-
dom bias in the current analysis, and to decrease the
statistical power for detecting significant differences.
Finally, the measurement error associated with bioim-
pedance analysis may have influenced the associations
Table 3 Multiple regression analysis to evaluate the association between anthropometric and body composition measurements with a cumu-
lative metabolic risk z score (dependent variable) in young and old overweight and obese women
Group models Young (N = 260) Old (N = 328)
B SE t p value B SE t p value
Model 1
R2 (F) 0.11 (15.6) \0.001 0.07 (7.9) \0.001
BAIBergman 0.02 0.04 0.52 0.60 -0.16 0.03 -4.71 <0.001
BMI (kg/m2) 0.12 0.04 2.79 0.006 0.18 0.04 4.12 <0.001
Model 2
R2 (F) 0.12 (12.2) \0.001 0.07 (8.0) \0.001
BAIBergman 0.06 0.04 1.31 0.19 -0.17 0.03 -4.65 <0.001
BMI (kg/m2) 0.006 0.07 0.06 0.94 0.21 0.07 2.99 0.003
WC (cm) 0.04 0.02 2.21 0.02 -0.01 0.02 -0.46 0.64
Model 3
R2 (F) 0.13 (7.6) \0.001 0.08 (5.7) \0.001
BAIBergman -0.06 0.04 1.37 0.17 -0.17 0.03 -4.58 <0.001
BMI (kg/m2) 0.53 0.68 0.79 0.42 0.01 0.18 0.07 0.94
WC (cm) 0.05 0.02 2.36 0.01 -0.006 0.02 -0.28 0.77
FMI (kg/m2) -0.59 0.67 -0.88 0.37 0.13 0.20 0.64 0.52
FFMI (kg/m2) -0.46 0.68 -0.68 0.48 0.29 0.16 1.82 0.06
Significant predictors are highlighted in bold
N number of subjects, BMI body mass index, WC waist circumference, HC hip circumference, BAI body adiposity index, FFMI fat-free mass
index, FMI fat mass index
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between BAI and the anthropometric adiposity indexes
and estimates of FM.
Conclusions
Our study contributes to the growing literature on BAI,
showing that, in line with previous results, the poor accu-
racy of BAI as an index of adiposity in young individuals
was observed. However, in older overweight and obese
women a paradoxical association of BAI with metabolic
risk was reported, suggesting that the validity and the
predictive value of this novel adiposity index may need to
be re-evaluated in older individuals in order to define the
predictive accuracy for the assessment of body adiposity.
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